NCT02592876 2019-05-17Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell LymphomaSeagen Inc.Phase 2 Terminated81 enrolled 15 charts
NCT00960063 2018-08-27A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)Merck Sharp & Dohme LLCPhase 1 Terminated4 enrolled 8 charts
NCT00250718 2015-08-03Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic ApproachNew Mexico Cancer Research AlliancePhase 2 Terminated17 enrolled 4 charts